MedPath
NMPA Approval

Recombinant Zoster Vaccine(CHO Cell)

S20190026

May 21, 2019

Drug Information

重组带状疱疹疫苗(CHO细胞)

欣安立适

注射剂

复溶后每1次人用剂量0.5ml,含gE蛋白50μg。

生物制品

May 21, 2019

May 20, 2024

Company Information

Applicant Company

Rue de l`Institut 89,B-1330 Rixensart, Belgium

Manufacturing Company

Parc de la Noire Epine, 20 Avenue Fleming, 1300 Wavre, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

重组带状疱疹疫苗(CHO细胞) - NMPA 批准文号 | MedPath